Delivery Order SPE2DB24D6041-SPE2DB25FKCNH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,957.42 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-competitive delivery order, with a firm fixed price structure, represents a child contract against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $12,767.10, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $7,190.64. The contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, utilizing firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under...
- The Defense Logistics Agency awarded a $11,966.22 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $29,915.39 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes under a firm fixed price contract. The award was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this medical supply delivery order. This delivery order operates as a...
- The Defense Logistics Agency awarded a $47,704.56 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $16,240.29 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on September 25, 2025, with completion expected by September 26, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This...
- The Defense Logistics Agency awarded a $18,113.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL syringes, with an ultimate completion date of September 9, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be performed in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,749.55 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The award specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $57,859.44 under a Firm Fixed Price contract type. This is a non-set-aside award, reflecting AmerisourceBergen's demonstrated capability to compete for federal pharmaceutical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCNHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,743.07 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on September 5, 2025, with completion scheduled for September 8, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled the order from its Corporate Office location in the same municipality. This delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This award is executed under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle, which positions the company as a key supplier within DLA's pharmaceutical supply chain supporting military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 9/5/25 |